Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Apr 1, 2024
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Buy(P)354$0.89$3151.0M
Mar 28, 2024Buy(P)3K$0.90$2K1.0M
Mar 27, 2024Buy(P)52K$0.90$46K1.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-028916) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML